Please login to the form below

Not currently logged in
Email:
Password:

Schiff Nutrition

This page shows the latest Schiff Nutrition news and features for those working in and with pharma, biotech and healthcare.

Reckitt to spin-off pharma unit as Indivior

Reckitt to spin-off pharma unit as Indivior

Meanwhile, RBP has been on the acquisition trial to boost its consumer health unit, busying Schiff Nutrition, OTC products from Bristol-Myers Squibb and Johnson &Johnson (J&J) subsidiary K-Y,

Latest news

  • Reckitt Benckiser confirms pharma spin-off plans Reckitt Benckiser confirms pharma spin-off plans

    nutrition and hygiene operations. ... The company has carried out a string of acquisitions to boost its consumer health unit, including Schiff Nutrition, OTC products from Bristol-Myers Squibb and Johnson &Johnson (J&J) subsidiary

  • Reckitt Benckiser backtracks on Merck OTC unit Reckitt Benckiser backtracks on Merck OTC unit

    The UK-based consumer healthcare company - which has already absorbed Schiff Nutrition, a stable of OTC products from Bristol-Myers Squibb and Johnson &Johnson subsidiary K-Y in the last few

  • Reckitt Benckiser may spin out pharma division Reckitt Benckiser may spin out pharma division

    is out of kilter with the rest of Reckitt, particularly in the wake of its acquisition of Schiff Nutrition for $1.4bn in 2012.

  • Lifestyle choices of consumer health Lifestyle choices of consumer health

    Battling for the emerging consumer healthcare market. Reckitt Benckiser Group:In November 2012, Reckitt Benckiser Group, a consumer goods company, announced that it had signed a merger agreement with Schiff Nutrition ... Originally Bayer had offered $34

  • BMS licenses OTC rights to Reckitt for $482m BMS licenses OTC rights to Reckitt for $482m

    Most notably, BMS divested infant nutrition unit Mead Johnson in 2009, a year after selling wound-care specialist ConvaTec and medical imaging unit Avista. ... Meanwhile, Reckitt has been steadily acquiring consumer health assets and shifting away from

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals during February 2013 Pharma deals during February 2013

    This deal will allow BMS to focus on its more innovative products in the region and Reckitt may be hoping that this deal, together with the acquisition of Schiff Nutrition in

  • Pharma deals during October 2012 Pharma deals during October 2012

    Near the close of the month, Bayer Healthcare announced the acquisition of US-based nutritional supplement company Schiff Nutrition International for $1.2bn at a share price premium of approximately 48 ... $m. Schiff Nutrition International/ Bayer.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics